Dr. Alina Amin, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1258 6th Ave, New York, NY 10020 Phone: 855-914-3478 |
Dr. Kathy L. Allen Aquilante, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 64 Watts St, New York, NY 10013 Phone: 718-945-9376 Fax: 718-945-9376 |
Dr. Paul M Breuer, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 495 Ft Washington Ave, New York, NY 10033 Phone: 212-928-1171 Fax: 212-543-0666 |
Dr. Kimberly Marie Mchugh, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 454 Lenox Ave, New York, NY 10037 Phone: 212-368-2020 Fax: 212-368-2029 |
Emergency Opthamology Services Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 550 Park Ave, New York, NY 10065 Phone: 714-289-1559 Fax: 714-289-0280 |
Dr. Jennifer Eileen Hue, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 33 W 42nd St, New York, NY 10036 Phone: 212-938-4001 |
Dr. Andrea Del Corro, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1010 2nd Ave, New York, NY 10022 Phone: 212-753-7733 Fax: 212-753-2677 |
Dr. Noelda Karen Fernandes, O.D Optometrist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 33 W 42nd St, New York, NY 10036 Phone: 212-938-4000 |
Dr. Diane E Calderon-villanueva, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 33 W 42nd St, New York, NY 10036 Phone: 212-389-4001 Fax: 212-938-5831 |
Dr. Frederic K Nevins, OD Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 22 W 13th St, New York, NY 10011 Phone: 212-807-0019 Fax: 212-727-2395 |
Dr. Melissa Lynn Carr, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 151 W 34th St, Macys Vision Express, New York, NY 10001 Phone: 212-494-7300 Fax: 212-494-1123 |
Dr. Edward Ruvio, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 79 Nassau St, New York, NY 10038 Phone: 212-349-1313 Fax: 212-608-6805 |
Viola Kanevsky, O.d., P.l.l.c. Optometrist Medicare: Medicare Enrolled Practice Location: 527 Columbus Ave, New York, NY 10024 Phone: 212-580-2020 Fax: 212-580-2023 |
Dr. Michael Eric Cotler, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 542 Fifth Ave., New York, NY 10036 Phone: 212-302-4889 Fax: 212-302-5831 |
May Ling Chung-han, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 139 Centre St, 610, New York, NY 10013 Phone: 212-966-5880 |
Kimberly Cheng, OD Optometrist Medicare: Medicare Enrolled Practice Location: 33 W 42nd St, New York, NY 10036 Phone: 212-938-4001 |
Park Avenue Optometry Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 287 Park Ave S Ste 1a, New York, NY 10010 Phone: 332-345-2363 Fax: 332-345-2364 |
Dr. Joel Warshowsky, DO Optometrist Medicare: Medicare Enrolled Practice Location: 33 W 42nd St, New York, NY 10036 Phone: 212-938-4000 Fax: 212-938-4135 |
Dr. Anne Lieber, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 40 W 116th St Apt B1005, New York, NY 10026 Phone: 917-526-1073 |
Dr. Marina Epelman Meyerowitz, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 33 W 42nd St, New York, NY 10036 Phone: 212-938-4000 |
News Archive
A dietary staple of India, where Alzheimer's disease rates are reportedly among the world's lowest, holds potential as a weapon in the fight against the disease.
The antimuscarinic drug fesoterodine seems to be an effective and well-tolerated treatment for elderly individuals with an overactive bladder, including those older than 75 years, show findings from a clinical trial.
A new class of compounds developed by two University of Kentucky researchers shows promise as a nontoxic treatment of some cancers previously treated with toxic chemotherapy, the researchers report.
People with type 2 diabetes who intensively controlled their blood sugar level during the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Eye Study were found to have cut their risk of diabetic retinopathy in half in a follow-up analysis conducted four years after stopping intensive therapy.
› Verified 4 days ago